BACKGROUND: We investigated the relationship between idiopathic recurrent pregnancy loss (RPL) and genetic polymorphisms in phase I and phase II detoxification genes which include CYP1A1, CYP2D6, GSTM1, GSTP1 and GSTT1. METHOD: A case-control study comprised 160 females with RPL and 63 healthy controls with a successful reproductive history. RESULTS: The CYP1A1 variant allele was present at frequencies of 0.61 and 0.44 in cases and controls, respectively (odds ratio 5 1.93; P 5 0.023, 95% confidence interval 1.10-3.38). The CYP2D6 variant allele was present at a frequency of 0.17 in females with RPL, while in the control population the frequency was 0.16. The GSTM1 and GSTT1 null genotypes were present at frequencies of 0.39 and 0.26 in RPL cases, whereas in controls the frequencies were 0.37 and 0.17, respectively. The mutant GSTP1 frequencies in case and control women were 0.38 and 0.40, respectively. We report a significant association of the CYP1A1*2A allele with RPL which is confirmed by logistic regression analysis. No association was observed for the other polymorphisms or in their combinations studied. CONCLUSIONS: The present study suggests the occurrence of the CYP1A1*2A allele as a probable risk factor in idiopathic recurrent miscarriages.
Introduction
An adequate amount of blood supply to the implantation site is critical for establishing a successful pregnancy. The maternal circulation through the placenta, however, is more restricted during the first few weeks of gestation. The placental circulation rises sharply to its full level at 10 -12 weeks of gestation, i.e. towards the end of the first trimester (Jauniaux et al., 2000) . During this period, there is an increased oxidative load in the placenta which facilitates events such as embryonic differentiation and development (Genbacev et al., 1997) . However, the placental oxidative stress may prove lethal to the developing embryo if there is excessive oxidative load or inefficient antioxidant defences which scavenge the load. The important role of maternal total antioxidant status in idiopathic infertility is documented (Polak et al., 2001) .
It is well known that the risk of miscarriage is enhanced by a variety of environmental as well as lifestyle factors such as stress, smoking, alcohol consumption, etc. (Sokol et al., 1980; Cnattingius et al., 1985) . All these factors were known to increase the oxidative stress through their activation and elimination by members of detoxification systems. The phase I detoxification activity, mostly carried out by the cytochrome P450 (CYP) family of enzymes, is inevitably associated with the generation of reactive oxygen species (ROS) such as hydroxy radicals, superoxide, peroxides, etc. Among the members of the CYP family, CYP1A1, Cyp1A2, Cyp2C, CYP2D6, Cyp2E1, Cyp2F1, Cyp3A4, Cyp3A5, Cyp3A7 and Cyp4B1 were found to be expressed in the placenta during the first trimester, although the functional activities of Cyp3A and Cyp4B were not detected (Hakkola et al., 1992) . The importance of CYP1A1 and Cyp2E1 in relation to pregnancy is substantiated further by the increased risk of miscarriage with maternal smoking and alcohol consumption. Experimental evidence indicates that during pregnancy, there is increased expression of CYP2D6 (Wadelius et al., 1997) , which metabolizes about one-quarter of clinically important medications. However, the exact role played by the enhanced CYP2D6 levels in pregnancy remains obscure.
The glutathione-S-transferase (GST) family of enzymes, being important members of phase II detoxification pathways, catalyse the conjugation of a variety of electrophilic substances to glutathione, facilitating their elimination from the body. Usually, the foreign substances activated by the phase I reactions are acted upon by the GST enzymes. Moreover, GST enzymes also play an important role in regulation of reduced glutathione levels, and thereby redox reserves of the individual. Hence any decrease in the GST activity can lead to accumulation of the products of phase I activity which can cause severe damage. GST enzymes are believed to play a crucial role in female reproduction as suggested by their presence in placenta and ovarian follicles in excessive amounts (Zusterzeel et al., 1999) . Among the various GST enzymes, GSTP1 is reported to be the predominant isoform in placenta, suggesting a possible role for this enzyme in pregnancy (Knapen et al., 1999a,b) .
Recurrent pregnancy loss (RPL) is defined as the incidence of three or more spontaneous miscarriages. It is a heterogeneous condition involving several aetiological factors. However, in about half of the cases, the exact reasons remain obscure (Shawky et al., 2000) . An association between RPL and GST gene polymorphisms was suggested by recent reports (Zusterzeel et al., 2000; Sata et al., 2003) . In the light of the above facts, we investigated the possible role played by CYP1A1, CYP2D6, GSTM1, GSTP1 and GSTT1 gene polymorphisms which are known to alter the activity or level of expression of these enzymes in RPL cases from the South Indian population.
Materials and methods

Patients
The present study was performed in 160 South Indian women with three or more first trimester miscarriages. The number of pregnancies lost varied from three to eight. All the females included are primary aborters with no live child. Routine diagnostic procedures such as karyotyping of the partners, torch test, identification of antiphospholipid antibodies and hysteroscopic examination were used to rule out known causes of pregnancy loss. None of them had any pregnancy-related complications such as hypertension, thyroid abnormalities, diabetes, etc. An ethnicity-matched control population of 63 females with at least one successful pregnancy outcome and without any history of spontaneous miscarriage or pregnancyassociated complication was used in the present study for comparing the results. Details regarding lifestyle habits as well as health status were obtained from all these women after personal counselling by the clinician. Informed written consent was obtained from all individuals. This study was approved by the Institutional Review Board.
DNA extraction
Genomic DNA was extracted from the EDTA-anticoagulated peripheral blood by the salting-out procedure (Miller et al., 1988) .
Genotype analysis
The CYP1A1*2A allele was detected by Msp I (New England Biolabs, Inc., Beverly, MA) digestion of a 340 bp fragment after PCR amplification using 5 0 CAGTGAAGAGGTGTAGCCGCT and 5 0 TAGGGAGTCTTGTCTCATGCCT primers. The CYP2D6*4 allele was detected by BstNI digestion of the PCR product amplified using the 5 0 GCCTTCGCCAACCACTCCG and 5 0 AAATCCTGCT-CTTCCGAGGC primer pair. The primers used for GSTM1 and GSTT1 genotyping were 5 0 CGCCATCTTGTGCTACATTGCCCG and 5 0 TTCTGGATTGTAGCAGATCA for GSTM1, and 5 0 GCCCT-GGCTAGTTGCTGAAG and 5 0 GCATCTGATTTGGGGACCACA for GSTT1. A 547 bp fragment from the NAT2 gene was co-amplified in each reaction as an internal control during GSTM1 and GSTT1 genotyping. The primer pair used for NAT2 amplification was GCTGGGTCTGGAAGCTCCTC and TTGGGTGATACATAC-ACAAGGG. The wild and heterozygous null genotypes were scored for a 230 bp fragment in the case of GSTM1 and a 112 bp product for GSTT1. For GSTP1 genotyping, a 176 bp fragment obtained by amplification using the ACCCCAGGGCTCTATGGGAA and TGA-GGGCACAAGAAGCCCCT primer pair was sequenced with a TaqDye deoxyterminator cycle sequencing kit (Applied Biosystems) using an automated ABI 3770 sequencer.
The PCRs were carried out in a total volume of 25 ml containing 10 mmol/l Tris -HCl (pH 8.3), 2.5 mmol/l MgCl 2 , 50 mmol/l KCl, 100 mmol/l each dNTP, 0.5 mmol/l each of the primer pair, 1.25 U of AmpliTaq Gold DNA polymerase (Roche Molecular Biochemicals) and 100 ng of template DNA. After pre-incubation at 948C for 5 min, the mixture was subjected to 35 cycles of 948C for 30 s, 598C for 30 s (638C for CYP1A1 and 608C for CYP2D6) and 728C for 30 s. A final extension at 728C for 10 min was carried out to complete extension of all DNA fragments.
Statistical analysis
The difference in frequencies between the case and control groups was analysed for statistical significance at the 95% confidence interval using Fisher's two-tailed test. Odds ratios (ORs) were calculated and reported within the 95% confidence limits. Unconditional multinomial logistic regression analysis was performed with different genotypes as well as genotype combinations as the independent factors, with the risk of RPL being the dependent variable. Factors which do not possess a significant Wald statistic, but tend to increase the P-value of the model, were selectively eliminated to obtain the final model. The statistical analyses were performed using SPSS for Windows (version 11.0) software. A P-value of ,0.05 was considered as significant in all the analyses.
Results
DNA samples obtained from 160 females with RPL and 63 females with a successful pregnancy history were analysed for null genotypes in GSTM1 and GSTT1, and the variant single nucleotide polymorphisms (SNPs) in GSTP1, CYP1A1 and CYP2D6. A post hoc power analysis according to Lalouel and Rohrwasser (2002) was carried out to check the strength of the study population in supporting the proposed model. It was found that our population size had a reasonably good power of 0.76 at a significance level of a ¼ 0.05 for the CYP1A1 variant frequencies observed. The characteristics of the study population are presented in Table I . The case and control groups were similar with respect to age, ethnicity and lifestyle habits. None of the women included in the present study were either smokers or alcohol consumers. The frequencies of various polymorphic alleles and genotypes studied along with the relevant statistical parameters for comparison are presented in Table II . None of the polymorphisms showed a correlation with age, as revealed by a low Pearson's correlation coefficient (P . 0.05; data not shown). In the case of GSTM1 and GSTT1 genotyping, the presence of at least one functional allele was scored for the wild genotype. The homozygous and heterozygous mutant frequencies were combined for CYP1A1, CYP2D6 and GSTP1 genotypes as the homozygous mutant frequencies were smaller to study their significance. The frequencies of GSTM1 nulls were 0.39 and 0.37 in the case and control groups, while those for GSTT1 nulls were 0.256 and 0.17, respectively. The mutant genotype frequencies for CYP1A1 were observed to be 0.606 in cases and 0.44 in controls; for CYP2D6, 0.175 in cases and 0.16 in controls; and for GSTP1, 0.381 in cases and 0.40 in controls. Among the various genotypes studied, the mutant CYP1A1 distribution was significantly different between the case and control groups as shown by a low Fisher's two-tailed P-value of 0.023 (, 0.05). When the distribution of various genotype combinations and their significance was analysed, none of the genotype combinations achieved association with the risk of RPL at a 95% significant level (data not shown).This can possibly be due to insufficient population size especially in the case of CYP2D6 as the variant allele frequency is very low. The results of multivariate logistic regression analysis of the data are presented in Table III . The developed model was significant at the 95% level (P ¼ 0.047) with a pseudo R 2 value (Nagelkerke) of 0.106. Among the various factors included in the model, the estimated logit coefficient [which is ln (OR)] for CYP1A1 mutant genotype was found to be significant as revealed by a significant Wald statistic of 6.7 (P ¼ 0.01). To validate the significance of CYP1A1 observed in the multivariate logistic regression model, a bivariate logistic regression with the Hosmer-Lemeshow goodness-offit test was performed on CYP1A1 distribution, the results of which supported the significance of CYP1A1 with an OR of 1.90 (P ¼ 0.03, data not shown).
Discussion
Apart from the established risk factors, detoxification mechanisms also play an important role in influencing the success of pregnancy outcome. Studying the effect of phase I as well as phase II gene polymorphisms in the context of oxidative stress influencing embryonic growth, development and hence the pregnancy outcome is gaining importance in recent years (Hong et al., 2002) . Many recent reports indicate the importance of these enzyme systems in human reproduction (Baranova et al., 1999; Hadfield et al., 2001; Chen et al., 2002) . However, no such study has been reported so far in RPL cases from the Indian subcontinent. Hence, we tried to study their relationship to the success of pregnancy.
CYP1A1 is mainly involved in the oxidation of polycyclic aromatic hydrocarbons which include compounds such as benzopyrene, polychlorinated biphenyls, etc. (Hasler et al., 1999) , the common environmental toxicants. The Msp I polymorphism (*2A allele) in the CYP1A1 gene is known to cause the high-inducible phenotype (Peterson et al., 1990; Cosma et al., 1993) , although the exact mechanism is not known. Another member of the CYP family, CYP2D6, also known as debrisoquine hydroxylase, is involved in the metabolism of a number of drugs. The major polymorphisms that are attributable to a decrease in CYP2D6 activity are the 2637deletion (*3) and G1934A transition (*4) (Bartsch et al., 
2000)
. From the data presented in Table II , we find no association between the CYP2D6*4 allele and the risk of RPL. However, a strong association between the occurrence of the CYP1A1 variant allele and the risk of pregnancy loss with an OR of 1.93 can be observed from the present data. The increased level of CYP1A1 enzyme due to the polymorphic allele can lead to increased risk of oxidative damage especially to the developing embryo. Moreover, during the first trimester of pregnancy, the activities of enzymes such as catalase, glutathione peroxidase and superoxide dismutase, which remove the ROS, are very low in the placenta (Hempstock et al., 2003) . As a result, any kind of oxidative stress imposed upon the developing embryo during the first trimester cannot be handled efficiently by either the embryo or the placenta, leading to severe damage. This can range from DNA damage and chromosomal aberrations to lipid peroxidation, cell lysis and fetal death. In addition, recent reports indicate the presence of dioxins, which are strong inducers of CYP1A1 expression, in human follicular fluid (Tsutsumi et al., 1998) . This suggests the possibility of constant induction of CYP1A1 at low levels in this tissue. The presence of a hyper-inducible allele in such an instance may increase the levels of CYP1A1 to the extent that it can cause severe damage to the fetus. The variant CYP2D6*4 allele, which is responsible for the poor metabolizer phenotype, does not appear to have a significant relevance in pregnancy.
GSTs conjugate reduced glutathione to a number of elecrophilic substances including the products of phase I detoxification reactions, thereby facilitating their elimination from the body. The deletion polymorphisms in GSTT1 and GSTM1 were reported (Seidegard et al., 1988; Pemble et al., 1994) to abolish their activity which, in turn, can lead to an imbalance between the phase I and phase II activities, increasing the risk of xenobiotic toxicity and oxidative stress. The importance of GSTM1 null polymorphism as a possible risk factor in pregnancy loss is validated through recent studies carried out in other populations (Sata et al., 2003) . GSTP1 is the major isoform of GSTs found in the follicular microenvironment (Knapen et al., 1999a,b) . A functional polymorphism at codon 105 (Ile ! Val) in the GSTP1 gene producing a less functional variant was reported to be associated with increased risk of RPL (Zusterzeel et al., 2000) . However, the present study failed to find an association between the risk of RPL and the deletion polymorphism in the GSTM1 and GSTT1 genes as well as the SNP in codon 105 of GSTP1 gene. From the results, GSTT1 and GSTM1 appear to play a minor role in pregnancy loss cases in the South Indian population. These results absolutely do not contradict the importance of decreased GST activity in RPL as suggested by previous studies. The damage that can occur to the early embryo due to decreased GST activity is overshadowed by the severe oxidative threat produced by excessive phase I, in particular CYP1A1, activity in the population studied. A cohort study aimed at measurement of the ROS in the follicular microenvironment in the background of a mutant CYP1A1, however, is necessary to prove the hypothesis.
To summarize, the present study revealed an association between the presence of a variant allele of CYP1A1 and the risk of recurrent early pregnancy loss. Other polymorphisms analysed in the present study failed to show any association. This study demonstrates the importance of detoxification gene polymorphisms in the context of oxidative stress and a threat to the survival of the embryo leading to pregnancy loss. Moreover, the presented data also reveal the importance of ethnicity in pharmacogenomic studies as the GSTP1 variant was not found to be associated with RPL in the South Indian population, unlike the case in many other populations. In addition, this is the first study from the Indian subcontinent regarding the involvement of detoxification gene polymorphisms in RPL. A study using populations from other parts of India will enable us to find the intra-regional variations and their relevance to RPL.
